Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 145 participants.

Also called NCT01244763

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 145 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01244763
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Puerto Rico (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01244763. Randomized; no masking; primary purpose treatment. Start 2010-10-29 (actual); primary completion 2012-06-13 (actual). Results posted on 2022-02-10.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia
Condition
Anemia
Intervention (Drug)
Roxadustat
Lead sponsor
Kyntra Bio (class: industry)
Collaborator
Astellas Pharma Inc (class: industry)

Record details

Record id
cardio:ct-nct01244763
Content hash
71320d2e13b54ef0d0f91171b5cf3ab6ec8b66503c39509f5c3455fb7d7080ff